BioSpace News Archive

CytRx Corporation today highlighted ImmunityBio, Inc.'s (NASDAQ: IBRX) (“ImmunityBio”) announced completion of enrollment in its Phase 2 trial studying a combination immunotherapy (Nant Cancer Vaccine)

Fabric Genomics and Rady Children’s Institute for Genomic Medicine ® today announced the publication of a retrospective study in Genome Medicine

ARTMS Inc. (ARTMS), the global leader in developing and commercializing novel products enabling cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce the submission of a Type 1 Master File with the Health Products & Food Branch, Health Canada (HC) for the production of gallium-68 (Ga-68).

Kriya Therapeutics, Inc. , a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced the appointment of Theresa Heah, M.D., MBA as Chief Medical Officer.

Exelixis, Inc. (Nasdaq: EXEL) and Aurigene Discovery Technologies Limited (Aurigene) today announced that Exelixis has exercised its exclusive option under the companies’ July 2019 agreement to in-license XL114

Natus Medical Incorporated announced today that the Company’s Board of Directors established an Environmental, Social, and Governance (ESG) committee and transitioned the role of the Quality & Compliance Committee to the Innovation & Quality committee on September 30th, 2021.

Quotient Limited, a commercial-stage diagnostics company, announced it has received unanimous consents from the holders of its 12% Senior Secured Notes to certain amendments to the Indenture governing the Notes.

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), and Augmenta Bioworks, a biotechnology company leveraging immune profiling technologies to enable breakthroughs in medicine, today announced the publication of a research paper highlighting positive preclinical study results of AUG-3387.

NeuroMetrix, Inc. announced that it plans to issue its 2021 third quarter financial results before the opening of the market on October 21, 2021.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced poster session and abstract data showcasing results of its rapid diagnostic technologies at several industry conferences throughout Sepsis Awareness Month.